#Coronavirus Disease Research #References (by AMEDEO, June 5 ’23)

1. YAO C, Parimon T, Espindola MS, Hohmann MS, et al.

Maladaptive TGF-beta Signals to the Alveolar Epithelium Drive Fibrosis After

COVID-19 Infection.

Am J Respir Crit Care Med. 2023 May 26. doi: 10.1164/rccm.202302-0264.

PubMed: http://www.amedeo.com/p2.php?id=37236627&s=cov&pm=2

Share: http://m.amedeo.com/37236627

2. TSOLAKI V, Zakynthinos GE, Papanikolaou J, Karavidas N, et al.

PEEP De-Escalation in Covid-19-induced Acute Respiratory Distress Syndrome

Unloads the Right Ventricle Improving Hemodynamics and Oxygenation.

Am J Respir Crit Care Med. 2023 May 26. doi: 10.1164/rccm.202301-0154.

PubMed: http://www.amedeo.com/p2.php?id=37236626&s=cov&pm=2

Share: http://m.amedeo.com/37236626

3. BUSE K, Gautam A, Hussain U, Olarewaju V, et al.

The dearth of disaggregated health data: a political rather than a technical

challenge.

BMJ. 2023;381:p1254.

PubMed: http://www.amedeo.com/p2.php?id=37263629&s=cov&pm=2

Share: http://m.amedeo.com/37263629

4. FLUXMAN J.

Comparing death rates in the pandemic: hundreds of millions could be disabled by

covid.

BMJ. 2023;381:p1230.

PubMed: http://www.amedeo.com/p2.php?id=37257908&s=cov&pm=2

Share: http://m.amedeo.com/37257908

5. TAYLOR L.

Covid-19: WHO treaty on future pandemics is being watered down, warn health

leaders.

BMJ. 2023;381:p1246.

PubMed: http://www.amedeo.com/p2.php?id=37257893&s=cov&pm=2

Share: http://m.amedeo.com/37257893

6. WU Q.

Understanding the burden of post-covid-19 condition.

BMJ. 2023;381:p932.

PubMed: http://www.amedeo.com/p2.php?id=37257892&s=cov&pm=2

Share: http://m.amedeo.com/37257892

7. BALLOUZ T, Menges D, Anagnostopoulos A, Domenghino A, et al.

Recovery and symptom trajectories up to two years after SARS-CoV-2 infection:

population based, longitudinal cohort study.

BMJ. 2023;381:e074425.

PubMed: http://www.amedeo.com/p2.php?id=37257891&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/37257891

8. LIN YY, Yao R, Zhuang J, Wang B, et al.

PACT inhibits the replication of SARS-CoV-2 through the blockage of GSK-3beta-N-nsp3

cascade.

J Med Virol. 2023;95:e28832.

PubMed: http://www.amedeo.com/p2.php?id=37264691&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/37264691

9. RAHMATI M, Yon DK, Lee SW, Udeh R, et al.

New-onset type 1 diabetes in children and adolescents as postacute sequelae of

SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies.

J Med Virol. 2023;95:e28833.

PubMed: http://www.amedeo.com/p2.php?id=37264687&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/37264687

10. QIAN X, Wu B, Chen X, Peng H, et al.

Multi-omic and comparative analyses revealed monocyte-derived alpha-defensin-1

correlated with COVID-19 severity and inhibited SARS-CoV-2 infection.

J Med Virol. 2023;95:e28845.

PubMed: http://www.amedeo.com/p2.php?id=37254949&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/37254949

11. REN Y, Wang G, Han D.

Statins in hospitalized COVID-19 patients: A systematic review and meta-analysis

of randomized controlled trials.

J Med Virol. 2023;95:e28823.

PubMed: http://www.amedeo.com/p2.php?id=37254831&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/37254831

12. GUO M, Zhu J, Hu Z, Wang Q, et al.

Histone mRNA polyadenylation-mediated inflammation underlies various virus

infections and cancers.

J Med Virol. 2023;95:e28826.

PubMed: http://www.amedeo.com/p2.php?id=37254821&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/37254821

13. ZENG G, Wang L, Li J, Zhang Z, et al.

Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in

hospitalized patients with COVID-19.

J Med Virol. 2023;95:e28836.

PubMed: http://www.amedeo.com/p2.php?id=37247396&s=cov&pm=2

Share: http://m.amedeo.com/37247396

14. BOSKOVIC B, Bilic I, Soda J, Kero I, et al.

Transcranial magnetic stimulation in assessment of vocal cord paralysis due to

post-viral (COVID-19) vagal neuropathy.

J Med Virol. 2023;95:e28838.

PubMed: http://www.amedeo.com/p2.php?id=37247386&s=cov&pm=2

Share: http://m.amedeo.com/37247386

15. MONDI A, Mastrorosa I, Piselli P, Cimaglia C, et al.

Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron

cocirculation, among patients hospitalized for COVID-19 in an Italian reference

hospital: Impact on clinical outcomes.

J Med Virol. 2023;95:e28831.

PubMed: http://www.amedeo.com/p2.php?id=37246793&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/37246793

16. GAULT N, Bachelet D, Laouenan C, Borie R, et al.

Impact of corticosteroids use on midterm sequelae in survivors of COVID-19

admitted to hospital: A prospective cohort study.

J Med Virol. 2023;95:e28819.

PubMed: http://www.amedeo.com/p2.php?id=37246784&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/37246784

17. HE H, Wang W, Li L, Zhang X, et al.

Activation of the NLRP1 Inflammasome and Its Role in Transmissible

Gastroenteritis Coronavirus Infection.

J Virol. 2023 May 31:e0058923. doi: 10.1128/jvi.00589.

PubMed: http://www.amedeo.com/p2.php?id=37255428&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/37255428

18. DAHNE J, Hawk LW Jr.

Health Equity and Decentralized Trials.

JAMA. 2023 Jun 1. doi: 10.1001/jama.2023.6982.

PubMed: http://www.amedeo.com/p2.php?id=37261810&s=cov&pm=2

Share: http://m.amedeo.com/37261810

19. Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and

response.

Lancet. 2023 May 26:S0140-6736(23)00964-9. doi: 10.1016/S0140-6736(23)00964.

PubMed: http://www.amedeo.com/p2.php?id=37247625&s=cov&pm=2

Share: http://m.amedeo.com/37247625

20. JAFFE S.

US health experts divided on social media age restrictions.

Lancet. 2023;401:1757.

PubMed: http://www.amedeo.com/p2.php?id=37245512&s=cov&pm=2

Share: http://m.amedeo.com/37245512

21. JONES JM, Manrique IM, Stone MS, Grebe E, et al.

Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2

Infections Among Blood Donors, by COVID-19 Vaccination Status – United States,

April 2021-September 2022.

MMWR Morb Mortal Wkly Rep. 2023;72:601-605.

PubMed: http://www.amedeo.com/p2.php?id=37262007&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/37262007

22. REIS G, Mills EJ, Glenn JS.

Pegylated Interferon Lambda for Covid-19. Reply.

N Engl J Med. 2023;388:2108.

PubMed: http://www.amedeo.com/p2.php?id=37256990&s=cov&pm=2

Share: http://m.amedeo.com/37256990

23. WANG M, Tang L, Huang L.

Pegylated Interferon Lambda for Covid-19.

N Engl J Med. 2023;388:2107-2108.

PubMed: http://www.amedeo.com/p2.php?id=37256989&s=cov&pm=2

Share: http://m.amedeo.com/37256989

24. ANDREAKOS E, Tsiodras S.

Pegylated Interferon Lambda for Covid-19.

N Engl J Med. 2023;388:2107.

PubMed: http://www.amedeo.com/p2.php?id=37256988&s=cov&pm=2

Share: http://m.amedeo.com/37256988

25. LENHARO M.

Global plan for dealing with next pandemic just got weaker, critics say.

Nature. 2023 Jun 1. doi: 10.1038/d41586-023-01805.

PubMed: http://www.amedeo.com/p2.php?id=37264132&s=cov&pm=2

Share: http://m.amedeo.com/37264132

26. RICHTERMAN A, Millien C, Bair EF, Jerome G, et al.

The effects of cash transfers on adult and child mortality in low- and

middle-income countries.

Nature. 2023 May 31:1-8. doi: 10.1038/s41586-023-06116.

PubMed: http://www.amedeo.com/p2.php?id=37258664&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/37258664

27. GAUTRET P.

Decline in rabies cases in international travelers during the COVID-19 pandemic.

Travel Med Infect Dis. 2023;54:102592.

PubMed: http://www.amedeo.com/p2.php?id=37245851&s=cov&pm=2

Share: http://m.amedeo.com/37245851

Published by

Giuseppe Michieli

I am an Italian blogger, active since 2005 with main focus on emerging infectious diseases such as avian influenza, SARS, antibiotics resistance, and many other global Health issues. Other fields of interest are: climate change, global warming, geological and biological sciences. My activity consists mainly in collection and analysis of news, public services updates, confronting sources and making decision about what are the 'signals' of an impending crisis (an outbreak, for example). When a signal is detected, I follow traces during the entire course of an event. I started in 2005 my blog ''A TIME'S MEMORY'', now with more than 40,000 posts and 3 millions of web interactions. Subsequently I added an Italian Language blog, then discontinued because of very low traffic and interest. I contributed for seven years to a public forum (FluTrackers.com) in the midst of the Ebola epidemic in West Africa in 2014, I left the site to continue alone my data tracking job.